Investigation of Alzheimer's Disease and Periodontal Status
NCT ID: NCT05807100
Last Updated: 2023-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2022-03-02
2023-01-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Relationship Between Periodontitis and Alzheimer's Disease in Terms of Blood Parameters
NCT07069244
Periodonitis and Alzheimer's Disease
NCT05189132
EFFECT OF PERIODONTAL TREATMENT ON ALZHEIMER DISEASE-ASSOCIATED OUTCOMES
NCT07233512
Periodontitis and Periodontal Bacteria in Dementia
NCT05557617
Treatment of Periodontal Disease in Patients With Alzheimer's Disease
NCT05183321
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this study, 90 individuals with AD, who were classified as Stage I, Stage II, and Stage III according to the Clinical Dementia Rating Scale. Baseline and 6th month cognitive status assessments of participants who met the inclusion criteria were performed in the Department of Neurology using SMMT. At the 6th month control appointment in the Neurology Department, the participants were referred to the Periodontology Department for oral examinations.
In the Periodontology Department, dental anamnesis of the patients was taken and intraoral examinations were performed. Periodontal examination of all existing teeth of all participants with at least one remaining tooth (excluding third molars) with a Williams-marked periodontal probe (Hu-Friedy, Chicago, Illinois, USA) and all molars and maxillary first premolars with Nabers probe (PQ2N, Hu-Friedy, Chicago, Illinois, USA) was performed and records %P (plak percentage), %BOP (percentage bleeding on probing), CAL (clinical attachment level), PPD (probing pocket depth). The position of the gingival margin and PPD were measured at six sites/teeth (including/excluding third molars). The CAL was then calculated from these measurements. In 2017, periodontal status was determined according to the decisions of the World Workshop on Periodontal and Peri-implant Diseases and Classification of Conditions. The current occlusal relationship status of all patients was evaluated using the Eichner Index and classified as Type 1 (A1-A2-A3-B1) , Type 2 (B2-B3) and Type 3 (B4-C1-C2-C3).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stage I
Stage I Alzheimer's Group (n=42): Individuals diagnosed with probable Alzheimer's disease with mild (early stage) dementia according to the Clinical Dementia Rating Scale.
Baseline Standardized Mini Mental Test
Cognitive status assessment was done with Standardized Mini Mental Test.
6th month Standardized Mini Mental Test
Cognitive status assessment was done with Standardized Mini Mental Test.
Stage II
Stage II Alzheimer's Group (n=29): Individuals diagnosed with probable Alzheimer's disease with moderate (moderate stage) dementia according to the Clinical Dementia Rating Scale.
Baseline Standardized Mini Mental Test
Cognitive status assessment was done with Standardized Mini Mental Test.
6th month Standardized Mini Mental Test
Cognitive status assessment was done with Standardized Mini Mental Test.
Stage III
Stage III Alzheimer's Group (n=19): Individuals diagnosed with probable Alzheimer's disease with severe (advanced stage) dementia according to the Clinical Dementia Rating Scale.
Baseline Standardized Mini Mental Test
Cognitive status assessment was done with Standardized Mini Mental Test.
6th month Standardized Mini Mental Test
Cognitive status assessment was done with Standardized Mini Mental Test.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Baseline Standardized Mini Mental Test
Cognitive status assessment was done with Standardized Mini Mental Test.
6th month Standardized Mini Mental Test
Cognitive status assessment was done with Standardized Mini Mental Test.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Do not have dementia other than Alzheimer type dementia.
* Does not have a psychiatric disorder effecting cognitive status and does not use drugs that effect cognitive status.
* Those who have other existing systemic diseases (cardiovascular disease, diabetes) under control other than Alzheimer's disease.
* Not using regular anti-inflammatory and corticosteroids
* C-Reactive Protein (CRP) value was measured within 6 months prior to the date of inclusion in the study.
* Non-smoker and no alcohol intake
* Have not received any dental treatment in the last 1 year
* In those with less than 10 teeth, the edentulousness was prosthetically rehabilitated.
Exclusion Criteria
50 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bezmialem Vakif University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmet AYDOĞDU
Role: STUDY_DIRECTOR
Bezmialem Vakif University
Özlem GELİŞİN
Role: STUDY_CHAIR
Bezmialem Vakif University
Şadiye GÜNPINAR
Role: STUDY_CHAIR
Bezmialem Vakif University
Kübra KARADURAN
Role: PRINCIPAL_INVESTIGATOR
Bezmialem Vakif University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bezmialem Vakif University
Istanbul, Fatih/Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Karaduran K, Aydogdu A, Gelisin O, Gunpinar S. Investigating the potential clinical impact of periodontitis on the progression of Alzheimer's disease: a prospective cohort study. Clin Oral Investig. 2023 Dec 30;28(1):67. doi: 10.1007/s00784-023-05445-w.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KKARADURAN001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.